These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21188325)

  • 1. NAT2 polymorphisms and sporadic colorectal cancer survival.
    Osian G; Procopciuc L; Vlad L; Iancu C; Cristea PG; Mocan T; Mocan L
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):361-8. PubMed ID: 21188325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.
    Osian G; Procopciuc L; Vlad L
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):347-53. PubMed ID: 17205146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma.
    Tamer L; Ercan B; Ateş NA; Değirmenci U; Unlü A; Ateş C; Dirlik M; Atik U
    Cell Biochem Funct; 2006; 24(2):131-5. PubMed ID: 15617035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
    Procopciuc LM; Osian G
    Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
    Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
    Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
    Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer.
    Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Lee H
    Environ Mol Mutagen; 2009 Mar; 50(2):127-33. PubMed ID: 19107910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between N-acetyltransferase 2 gene polymorphisms and pancreatic cancer.
    Ayaz L; Ercan B; Dirlik M; Atik U; Tamer L
    Cell Biochem Funct; 2008 Apr; 26(3):329-33. PubMed ID: 18027363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
    Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.
    Sørensen M; Autrup H; Olsen A; Tjønneland A; Overvad K; Raaschou-Nielsen O
    Cancer Lett; 2008 Aug; 266(2):186-93. PubMed ID: 18372103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans.
    Moonen H; Engels L; Kleinjans J; Kok Td
    Cancer Lett; 2005 Nov; 229(1):25-31. PubMed ID: 16157215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-actyltransferase2 polymorphism in recurrence of colorectal polyps and adenomas].
    Zheng S; Liu X; Cao J
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):907-9. PubMed ID: 11702663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
    Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.